ClinicalTrialsFinder

Borderline Resectable Pancreatic Ductal Adenocarcinoma Clinical Trials in Seoul, Select Province/State

1 recruitingSeoul, Select Province/State, South Korea

Showing 1–1 of 1 trials

Recruiting
Phase 2

PULSAR in Systemic Therapy for Pancreatic Cancer

Borderline Resectable Pancreatic Ductal AdenocarcinomaLocally Advanced Pancreatic Ductal AdenocarcinomaOligometastatic Pancreatic Ductal Adenocarcinoma
Samsung Medical Center47 enrolled1 locationNCT07269626